SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-21-015885
Filing Date
2021-11-15
Accepted
2021-11-15 08:59:06
Documents
15
Period of Report
2021-11-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.02: Results of Operations and Financial Condition
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K kala-20211112x8k.htm   iXBRL 8-K 77181
2 EX-2.1 kala-20211112xex2d1.htm EX-2.1 838406
3 EX-10.1 kala-20211112xex10d1.htm EX-10.1 125792
4 EX-99.1 kala-20211112xex99d1.htm EX-99.1 218330
  Complete submission text file 0001558370-21-015885.txt   1594514

Data Files

Seq Description Document Type Size
5 EX-101.SCH kala-20211112.xsd EX-101.SCH 3150
6 EX-101.LAB kala-20211112_lab.xml EX-101.LAB 16587
7 EX-101.PRE kala-20211112_pre.xml EX-101.PRE 10459
8 EXTRACTED XBRL INSTANCE DOCUMENT kala-20211112x8k_htm.xml XML 5105
Mailing Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472 781-996-5252
Kala Pharmaceuticals, Inc. (Filer) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38150 | Film No.: 211406690
SIC: 2834 Pharmaceutical Preparations